Congratulations to Taylor Eggertsen on passing his PhD proposal today!!! 🎉 Jeff Saucerman Virginia BME

Overview of my Cardiac Systems Biology Group, with highlights of student projects on cardiac regeneration, hypertrophy, and fibrosis. youtu.be/G9UVxBeGuSU

Happy to share our latest preprint by Matt van de Graaf and Taylor Eggertsen. We test 4 protein interaction databases for their ability to recover interactions from 3 large-scale manually curated signaling networks. 1/3 biorxiv.org/cgi/content/sh…

Irina Bochkis UVA Pharmacology discovered that changes in nuclear shape alter lamina-chromatin interactions and binding of FOXA2, predictive of liver disease in mice+humans. Happy to collab with nuclear shape analysis by Taylor Eggertsen. Genome Research newsroom.uvahealth.com/2023/02/08/uva…

Congratulations to the Bochkis lab! So grateful I could collaborate with this work! pharm.virginia.edu/blog/2023/02/0…

m.genome.cshlp.org/content/32/11-…

UVA Pharmacology Taylor Eggertsen Genome Research This study on wrinkly nuclei was also covered on @NBC29 nbc29.com/2023/02/08/uva…

First paper by Anders R Nelson accepted! We also enjoyed our first collaboration with Darrian Bugg, PhD and Jen Davis. #fibroblast

Link to the full article: academic.oup.com/cardiovascres/…

2 talks, 3 posters, and 3 trips to the beach by Saucerman Group at #CardiacPhysiome in Irvine. Taylor Eggertsen @muktichowkwale Anders R Nelson Lionel

I’m very excited to receive the notice of award for my F31! It is titled “Virtual drug screen reveals context-dependent inhibition of cardiomyocyte hypertrophy.” Big thanks to Saucerman Group and UVA CVRC for making this research possible!

Very proud of Taylor Eggertsen for publishing his first paper, "Virtual drug screen reveals context-dependent inhibition of cardiomyocyte hypertrophy"! His network model predicts 52 FDA-approved drugs that regulate heart cell growth. bpspubs.onlinelibrary.wiley.com/doi/abs/10.111…

Saucerman Group’s very own Bryana Nycole Harris has co-founded the Society for Black Biomedical Scientists and Engineers at UVA, along with @Syn_Gibbs! Virginia BME UVA_BIMS 🔬🥽🎓 @DiversityUVASOM UVA Engineering

.UVA biomedical engineering Ph.D. student Taylor Eggertsen is using biological modeling tools to find a medicine that could prevent heart failure.💻🧡💙 Saucerman Group UVA Cardio More: at.virginia.edu/Wqv0oW

Midostaurin is a chemotherapy drug used to fight bone-marrow cancer. But a new drug-screening tool suggests that it could also treat and prevent heart failure. Jeff Saucerman Saucerman Group Taylor Eggertsen #HeartFailure #chemotherapy ow.ly/2nGx50PLxUK

Listen to Taylor Eggertsen Saucerman Group's solo(!) interview on public radio, where he describes his network modeling to repurpose a cancer drug against cardiac hypertrophy. #proudmentor #scicomm wvtf.org/news/2023-10-0…

Inviting you to the free virtual Netflux and Logic-based Network Biology Meeting on Jan 16. Talks by trainees using our user-friendly Netflux software and other logic-based methods to simulate networks. Keynote by Jay Humphrey Yale BME. Please RT. docs.google.com/document/d/1ZW…

Come join Saucerman Group to discover drugs for heart failure and regeneration with systems biology! Postdocs UVA CVRC open and free no-GRE PhD app due 12/15 Virginia BME.

Celebrating Taylor Eggertsen's magical PhD dissertation,"Systems Pharmacology Approaches Identify Drugs and Mechanisms That Regulate Cardiomyocyte Growth"! Saucerman Group Virginia BME

Congratulations to Bryana Nycole Harris on her outstanding PhD defense, "A Comprehensive Systems Biology Approach to Identify Novel Mechanisms Regulating Cardiomyocyte Proliferation"! Virginia BME BlackInBME